Most studies on TCF7L2 SNP variants in the pathogenesis of type 2 diabetes (T2D) focus on a role of the encoded transcription factor TCF4 in b cells. Here, a mouse genetics approach shows that removal of TCF4 from b cells does not affect their function, whereas manipulating TCF4 levels in the liver has major effects on metabolism. In Tcf7l2 À/À mice, the immediate postnatal surge in liver metabolism does not occur. Consequently, pups die due to hypoglycemia. By combining chromatin immunoprecipitation with gene expression profiling, we identify a TCF4-controlled metabolic gene program that is acutely activated in the postnatal liver. In concordance, adult liver-specific Tcf7l2 knockout mice show reduced hepatic glucose production during fasting and display improved glucose homeostasis when maintained on high-fat diet. Furthermore, liver-specific TCF4 overexpression increases hepatic glucose production. These observations imply that TCF4 directly activates metabolic genes and that inhibition of Wnt signaling may be beneficial in metabolic disease.
INTRODUCTION
Wnt signaling controls virtually every aspect of embryonic development and mediates homeostatic self-renewal in adult tissues (Clevers and Nusse, 2012) . When Wnt ligands bind to the Frizzled-Lrp5/6 receptor complex, it results in the stabilization and subsequent nuclear translocation of b-catenin. In the nucleus, stabilized b-catenin binds to TCF transcription factors to regulate the transcription of Wnt target genes.
Epidemiological evidence suggests that Wnt signaling may also play a role in metabolic disorders. Grant and colleagues identified a strong association between T2D risk and intronic SNPs in TCF7L2 (Grant et al., 2006) . Many follow-up studies have confirmed this discovery (Cauchi et al., 2007; Elbein et al., 2007; Florez et al., 2006) . Individuals with variants of TCF7L2 associated with increased risk for T2D show impaired insulin secretion Saxena et al., 2006) and present an increased hepatic glucose production in fasting (Lyssenko et al., 2007) .
Tcf7l2 mutant mice, which die in the immediate postnatal period, do not maintain stem cells in their intestinal crypts (Korinek et al., 1998) . Moreover, the encoded TCF4 transcription factor activates the oncogenic program that is aberrantly activated in APC mutant colon cancer cells (Korinek et al., 1997; van de Wetering et al., 2002) . In a recent study by Nobrega and colleagues, copy numbers of Tcf7l2 were varied by transgenesis. Increased copy numbers of Tcf7l2 rendered mice glucose intolerant, whereas decreasing gene copy numbers resulted in enhanced glucose tolerance (Savic et al., 2011) . These observations imply that the human risk alleles of TCF7L2 represent gain-of-function alleles for an as-yet-undefined role of TCF4 in metabolic control. Here, we address the tissue of action and the molecular mechanism of metabolic control by TCF4 by using mouse models allowing constitutive knockout, tissue-specific knockout, and transient overexpression of Tcf7l2.
littermates. TCF4 heterozygosity reduces glucose, insulin, fatty acid, triglyceride, and cholesterol levels in adult mice (data not shown). Tcf7l2 +/À mice also have increased insulin sensitivity, improved glucose tolerance, and reduced capacity to produce glucose after pyruvate injection, even when they are fed with a 45% high-fat (HF) diet (data not shown), confirming previous observations (Savic et al., 2011) . Human carriers of the risk variants for TCF7L2 reportedly display impaired insulin secretion Saxena et al., 2006) . We generated a Tcf7l2 allele with loxP sites flanking exon 10 (van Es et al., 2012) , which encodes the DNA-binding HMG box (Korinek et al., 1998) . Tcf7l2 loxP/+ mice were bred with the tamoxifen-inducible pancreatic b-cell-specific Cre recombinase strain RIP-Cre-ER T2 (Dor et al., 2004 ). Because we did not observe any difference between the three controls (Tcf7l2 loxp/loxp , RIP-Cre-ER T2 , and WT) in body weight, blood glucose and plasma insulin levels, glucose tolerance test, and insulin secretion in vivo in the initial experiments (Figures S1A-S1E available online), we decided to use in the follow-up experiments Tcf7l2 loxp/loxp ; RIP-Cre-ER T2 (bTCF4KO) and Tcf7l2 loxp/loxp as control mice. Both groups of mice were injected with tamoxifen at weaning and were analyzed at the age of 2 to 3 months.
PCR and real-time RT-PCR were performed to quantify recombination of the Tcf7l2 locus and depletion of Tcf7l2 messenger RNA (mRNA) in b cells. As shown in Figure S2A , a single 1,132 bp band was observed in islets from controls. In contrast, by using DNA prepared from islets from bTCF4KO mice, the major product was 611 bp, indicating exon 10 deletion. Tcf7l2 mRNA was strongly reduced in isolated islets from bTCF4KO mice ( Figure 1K ). The remaining Tcf7l2 mRNA can be accounted for by the fact that b cells only make up $80%-85% of islets.
We compared a set of metabolic parameters between adult bTCF4KO mice and control littermates on normal chow (NC) diet (Figure 1) . Surprisingly, bTCF4KO mice were able to maintain euglycemia as compared to control littermates in the fed and the fasted state ( Figure 1A ). We did not detect any difference either in plasma insulin levels ( Figure 1B ) or in the ratio insulin/ glucose ( Figure 1C ) in both states. When mice were exposed to a 45% HF diet ( Figure S2 ), we observed no differences in body weight, gain of body weight, food intake, blood glucose, and plasma insulin levels between bTCF4KO and control mice ( Figures S2B-S2G ). To characterize physiological responses to glucose load, bTCF4KO and control mice on either NC (Figure 1D ) or HF ( Figure S2H ) diet were subjected to an intraperitoneal (i.p.) glucose tolerance test after a 16 hr fast. This revealed no difference in glucose tolerance on either NC ( Figure 1D ) or HF ( Figure S2H ) diet. When mice on either NC ( Figure 1E ) or HF ( Figure S2I ) diet were injected with insulin to test their insulin tolerance, we did not observe any difference between both genotypes.
Then, insulin release was measured in response to glucose stimulation in vivo. The increase in plasma insulin levels 15 min after i.p. glucose injection did not differ between bTCF4KO and control mice on either NC ( Figure 1F ) or HF diet ( Figure S2J ). We also isolated pancreatic islets from bTCF4KO and control mice on either NC ( Figure 1G ) or HF ( Figure S2K ) diet for 8 weeks and tested insulin secretion in vitro. Under both feeding conditions, insulin release was equal at low (1.6 mM) and high (16.7 mM) glucose concentrations between bTCF4KO and control mice. Total insulin content did not differ between islets isolated from bTCF4KO and control mice in both feeding conditions ( Figures 1H and S2L) . Accordingly, histological analysis revealed no differences in pancreatic islets and in b cell mass ( Figure 1I ). Ki67 staining also revealed no effect of TCF4 deletion on b cell proliferation ( Figure 1J ).
We also measured the mRNA levels of genes relevant for maintaining b cell function in isolated pancreatic islets. As expected, Tcf7l2 mRNA levels were dramatically reduced in the pancreatic islets of bTCF4KO mice (p < 0.01) (Figures 1K and S2M) . Levels of Ins1 and Ins2 and Gcg and Iapp were indistinguishable from that of control mice both on NC ( Figure 1K ) and HF ( Figure S2M ) diets. Neither the mRNA levels for enzymes involved in glucose metabolism (Gck, Pklr, and G6pc2) nor receptors for insulin release and glucose sensing (Insr, Gipr, Glp1r, and Slc2a2) were affected by depletion of TCF4. Moreover, the expression of b cell transcription factors (Pdx1, NeuroD1, Nkx2.2, Nkx6.1, Isl1, and FoxO1) was not affected in isolated pancreatic islets of bTCF4KO mice (both on NC [Figure 1K] and HF [ Figure S2M ] diets). Of interest, Axin2 and Sp5, two generic Wnt target genes (Lustig et al., 2002; Weidinger et al., 2005) , showed no change both on NC ( Figure 1K ) and HF ( Figure S2M ) diets, implying that TCF4-dependent Wnt signaling is not operative in pancreatic b cells.
Tcf7l2
À/À Newborns Die Because of Hypoglycemia
The lack of a metabolic phenotype of the bTCF4KO mice prompted us to reassess the Tcf7l2 À/À model. Tcf7l2 À/À newborns appeared developmentally normal at birth yet displayed a reduced body weight ( Figure 2A ). They became lethargic within hours after birth, presumably because of lack of energy to compete for nourishment, and typically died after 8 hr ( Figure 2D ). Just after birth, glucose levels appeared indistinguishable between Tcf7l2
, and Tcf7l2 À/À newborns (data not shown). However, glucose levels were significantly lower at 3 hr postpartum (hpp) in the Tcf7l2 À/À newborns ( Figure 2B) than in littermates. The hypoglycemia was caused neither by glycosuria (data not shown) nor by excessive insulin secretion, as plasma insulin levels were also significantly lower in Tcf7l2
mice than in their Tcf7l2 +/+ and Tcf7l2 +/À littermates ( Figure 2C ). The Tcf7l2 À/À newborns could be rescued for up to 32 hr by subcutaneous injections of 50 ml of 10% glucose at birth and every 6 hr thereafter (p < 0.001) ( Figure 2D ).
Hepatic Glucose Metabolism Is Affected in Tcf7l2
À/À Newborns To circumvent confounding consequences of feeding, we removed all pups from the mothers directly after birth and analyzed metabolic parameters 5 hr later (5 hpp). To ensure survival of the newborns, all mice were given a single subcutaneous glucose injection at birth. Blood glucose levels and plasma insulin levels were indistinguishable between 5 hpp Tcf7l2 +/+ , Tcf7l2 +/À , and Tcf7l2 À/À ( Figures 3A and 3B) newborns. This was in line with the previous results obtained in adult mice, where the absence of TCF4 did not prevent b cells from secreting insulin after glucose stimulation. Indeed, embryonic development of the endocrine pancreas, b cell proliferation, and expression of relevant b cell genes appeared normal in Tcf7l2 À/À newborns ( Figures S3A-S3C ).
The liver occupies a central position in metabolic adaptation after birth, particularly in glucose homeostasis. Initially, hepatic glucose is released from glycogen stores. After several hours of fasting, gluconeogenesis, the production of glucose from lactate and pyruvate, becomes the major source of glucose (Gustafsson, 2009; Pilkis and Granner, 1992) . We analyzed Figure 3C , top), implying that glycogen metabolism is not affected by TCF4 during embryonic development. In contrast, histological sections and measurement of glycogen content of liver samples from 5 hpp Tcf7l2 À/À mice revealed strongly reduced glycogen storage (p < 0.01) ( Figure 3C , bottom, and Figure 3D ). mRNA expression levels of enzymes important for glycogen metabolism (Gys2, Pygl, and Gyg) and gluconeogenesis (Pck1, G6pc, and Fbp1) were analyzed by qRT-PCR in embryonic and 5 hpp Tcf7l2 À/À and WT livers. Expression of Gys2, the enzyme that catalyzes the rate-limiting step in the synthesis of glycogen (Ferrer et al., 2003) , was significantly downregulated in 5 hpp Tcf7l2 À/À livers (p < 0.05) ( Figure 3E ). Consistent with an activation of the gluconeogenic pathway at birth, Pck1, G6pc, and Fbp1 mRNA levels were upregulated in the WT newborn livers compared with the embryonic livers. The induction of Pck1 and G6pc was significantly reduced in the 5 hpp Tcf7l2 À/À newborn livers when compared with WT littermates (p < 0.05) ( Figure 3F ).
Tcf7l2
À/À Newborns Have Disrupted Hepatic Lipid Metabolism After birth, triglyceride synthesis, fatty acid oxidation, and ketone body synthesis are also enhanced in the early postnatal liver (Ferré et al., 1986) . To determine the effect of TCF4 depletion on lipid metabolism, concentrations of free fatty acids (FFA), triglycerides, and ketone bodies were measured in the serum of 5 hpp Tcf7l2 +/+ , Tcf7l2
, and Tcf7l2 À/À newborns, previously removed from their mothers and injected with glucose at birth. Serum FFA, triglycerides, and ketone bodies levels were significantly reduced in 5 hpp Tcf7l2 À/À newborns (p < 0.01 and p < 0.05) ( Figures 4A-4C ). We then assessed hepatic lipid distribution with oil red O staining. Embryonic livers from WT and Tcf7l2 À/À mice were indistinguishable, presenting few small lipid droplets ( Figure 4D , top). However, 5 hpp WT livers showed a strong increase in lipid, which was not observed in Tcf7l2
livers ( Figure 4D , bottom). In concordance, triglyceride content was significantly reduced in 5 hpp Tcf7l2 À/À livers when compared with Tcf7l2 +/+ and Tcf7l2 +/À (p < 0.01) ( Figure 4E ).
Changes in serum and hepatic lipid levels were possibly secondary to changes in gene expression of relevant enzymes in hepatic lipid metabolism. Indeed, the upregulation of genes involved in different aspects of fatty acid biosynthesis observed in 5 hhp WT livers was again abolished in 5 hpp Tcf7l2 À/À livers.
This included Acadl and Ehhadh (p < 0.05 and p < 0.01) (Figure 4F) . Similarly, decreases were detected in the expression of several enzymes involved in b-oxidation, such as Acaa1a and Acot4 (p < 0.05 and p < 0.01) ( Figure 4G ), and genes implied in ketogenesis and cholesterol metabolism, such as Fgf21, Akr1c6, and Cyp7a1 (p < 0.05) ( Figure 4H ).
Strong Upregulation of Wnt, Liver-Zonated, and Metabolic Genes in Postnatal Livers in a TCF4-Dependent Manner
The failed postnatal upregulation of multiple metabolic genes prompted us to address the possibility that these genes are regulated by the Wnt pathway effector TCF4. To identify the hepatic transcriptional signature dependent on TCF4, we performed comparative gene expression profiling on livers of 5 hpp newborns. 960 genes were differentially expressed between Tcf7l2 À/À and Tcf7l2 +/+ livers (as arbitrarily defined by >2-fold , and Tcf7l2 À/À newborns.
(D) After subcutaneous administration of glucose at birth and every 6 hr thereafter, the life span of the Tcf7l2 À/À newborns can be extended significantly (p < 0.0001) compared with nontreated Tcf7l2 À/À newborns.
Data are represented as mean ±SEM. *p < 0.05, **p < 0.01, and ***p < 0.001; n = 12-15 per genotype. See also Figure S3 . expression difference; p < 0.05) (Table S1 and Figure 5A ). In the list of genes with lower expression in the mutant mice, we found metabolic genes such as Aqp9, Slc17a2, and Akr1c6. We also noted differential expression levels of the generic Wnt target genes Axin2 and Sp5 between Tcf7l2 À/À and Tcf7l2 +/+ neonatal livers ( Figure 5D ). A previous report has implicated Wnt signaling in the zonation of genes in adult liver and has identified several liver-specific Wnt/b-catenin target genes such as Glul and All data are represented as mean ±SEM; n = 6-12 per genotype; *p < 0.05 and **p < 0.01.
Rnase4 (Benhamouche et al., 2006) . These Wnt-driven zonation genes were also differentially expressed between Tcf7l2 À/À and Tcf7l2 +/+ neonatal livers ( Figure 5E ). These observations implied that Wnt signals, mediated through TCF4, are operative in the early postnatal liver.
Given that the metabolic phenotypes were observed in Tcf7l2 À/À postnatal livers, but not during embryonic development, we hypothesized that TCF4 transcriptional target gene expression may follow the same pattern. As expected, there were no significant differences in the mRNA levels of the two prototypic Wnt-responsive genes Axin2 and Sp5 in Tcf7l2
embryonic livers when compared with WT littermates ( Figure 5D ). When we compared mRNA levels between late embryonic and 5 hpp WT livers, we noted a dramatic upregulation of these generic Wnt target genes ( Figure 5D ), implying that the Wnt pathway is acutely activated directly after birth. This induction did not occur in the Tcf7l2 À/À newborn livers (p < 0.05) ( Figure 5D ). Indeed, we observed an increase in the expression levels of several Wnt genes in postnatal livers when compared with their embryonic levels (p < 0.05 and p < 0.01) ( Figure 5C ). There was also a significant upregulation after birth of the liver-zonated Wnt-target genes Glul and Rnase4, again in a TCF4-dependent manner (p < 0.05) ( Figure 5E ). Of note, Tcf7l2 mRNA levels were not increased after birth ( Figure 5B ). As noted above, the microarray list of genes that were low in Tcf7l2 À/À newborn livers compared to controls contained multiple genes relevant to the metabolic functions of the liver, such as Aqp9, an essential glycerol transporter (Rojek et al., 2007) ; Cyp2e1, a monooxygenase member of the cytochrome P450 superfamily that catalyzes steps in the synthesis of cholesterol, steroids, and other lipids (Lieber, 1997) ; and Hmgcs2, the rate-limiting enzyme in the ketogenesis pathway, providing lipid-derived energy in neonates and in times of carbohydrate deprivation (Dashti and Ontko, 1979) (Table S1 ). In line with the previous observations in Wnt and liver-zonated genes, metabolic genes such as Cyp2e1, Cyp2c39, Hmgcs2, Aqp9, Slc17a2, and Slc27a2 were significantly upregulated postnatally in WT livers, but such upregulation did not occur in the Tcf7l2 À/À postnatal livers (p < 0.05 and p < 0.01) ( Figure 5F ). These differences were also observed between 5 hpp Tcf7l2 +/+ and Tcf7l2 À/À livers at the protein level by immunostaining and western blot analysis for AQP9, CYP2E1, and SLC27A2 ( Figures S4A and S4B ). Data are represented as mean ±SEM; n = 8 per genotype; *p < 0.05, **p < 0.01, and ***p < 0.001. See also Figure S4 and Table S1 .
TCF4 Directly Regulates the Expression of Key Genes Involved in Metabolic Pathways
The transcriptional signature of Tcf7l2 À/À postnatal livers suggested that TCF4 might activate the expression of the pertinent metabolic genes directly. We performed chromatin immunoprecipitation sequencing (ChIP-seq) experiments on chromatin prepared from livers of 1-week-old WT mice. 5,092 potential TCF4 binding sites were identified (at a 10% false discovery rate) ( Figures 6A, 6B , S5A, and S5B and Table S2 ). The most common sequence motif in the TCF4-binding regions closely resembled the cognate TCF-binding motif ( Figure 6C and Table  S3 ) (Hatzis et al., 2008; van de Wetering et al., 1997) . GSEA analysis showed a significant enrichment of genes with TCF4 binding sites within 5 kb from their transcription start sites (TSSs) among the genes with decreased expression in newborn Tcf7l2 À/À livers ( Figure 6D ). Thus, we identified TCF4 peaks in the TSSs of general Wnt target genes such as Axin2 and Sp5 (Hatzis et al., 2008) , which coincided with similar peaks in intestinal crypt chromatin ( Figures 6A and S5A ). We also identified TCF4 peaks in the vicinity of the TSSs of the liver-zonated genes Glul and Rnase4 ( Figures 6A and S5A ). These results were confirmed by qPCR (p < 0.05, p < 0.01, and p < 0.001) ( Figures 6E and S5C) . We then performed Gene Ontology (GO) analysis (Eden et al., 2009 ) on a set of genes defined as being >1.5-fold downregulated in the Tcf7l2 À/À postnatal livers and containing at least one TCF4-bound region within 5 kb from the TSS. Among the functional categories significantly enriched in this gene set (p < 0.001), the overwhelming majority was involved in metabolic processes, including carbohydrate, steroid, ketone, and lipid metabolism (Table S4) . Among these key liver metabolic genes identified as novel TCF4 target genes, we noted, among others, Aqp9, Acadl, Akr1c6, Cyp2e1, Cyp2c39, Slc25a21, and Hmgcs2a ( Figures 6B, 6E , S5B, and S5C). As a further validation to the ChIP-seq data, we cloned the Sp5, Rnase4, Cyp2e1, and Akr1c6 promoters and the putative Aqp9 enhancer in a luciferase reporter plasmid. Transient transfections were performed in HepG2 cells, a human hepatocarcinoma cell line in which Wnt signaling is constitutively active due to a b-catenin mutation (de La Coste et al., 1998) . Figure 6F shows spontaneous activity of the b-catenin/TCF reporter plasmid TOPflash (Korinek et al., 1997) and of all putative regulatory sequences due to the activation of Wnt signaling in this cell line. As a negative control, we used the mutant FOP reporter plasmid ( Figure 6F) . In order to demonstrate that the measured transcriptional activity was dependent on TCF4, all constructs were cotransfected with a TCF4 dominant-negative (DNTCF4) expression plasmid (Hatzis et al., 2008; van de Wetering et al., 2002) . As expected, luciferase activity was significantly reduced upon DNTCF4 overexpression (and consequent reduction of WT TCF4 activity) (p < 0.05 and p < 0.01) ( Figure 6G ), corroborating that this set of metabolic genes is regulated directly by TCF4.
In Adult Liver, TCF4 Is Involved in the Transcriptional Activation of Genes Implicated in the Response to Fasting As TCF4 is a critical regulator of neonatal hepatic metabolism in vivo and as a loss of TCF4 leads to lethal hypoglycemia in newborn mice, we investigated whether depletion of TCF4 in adult liver would alter glucose homeostasis. For the generation of liver-specific TCF4 knockout mice (LTCF4KO), we followed the same strategy that we have described previously for generating bTCF4KO mice but instead bred Tcf7l2 loxP mice with the tamoxifen-inducible liver-specific Cre recombinase strain SACre-ER T2 (Schuler et al., 2004) . In all experiments, Tcf7l2 loxp/loxp ;
SA-Cre-ER T2 (LTCF4KO) and Tcf7l2 loxp/loxp control mice were injected with tamoxifen after weaning and were analyzed at the age of 2 to 3 months. To determine the efficiency of recombination of the Tcf7l2 gene in the liver, genomic PCR and real-time PCR were performed. As shown in Figure S6A , recombination took place specifically in DNA samples from LTCF4KO livers. In concordance, expression of Tcf7l2 mRNA was strongly reduced in the livers from LTCF4KO mice when compared with control mice ( Figure S6B ). LTCF4KO mice did not differ in body weight from their control littermates on NC diet ( Figure S6D ). However, we observed significantly reduced glucose levels in fasting LTCF4KO mice when compared to control mice ( Figure S6G) . This reduced glucose level was not caused by hyperinsulinemia ( Figures S6H and S6I) . Indeed, glucose-stimulated insulin secretion did not differ between LTCF4KO and control mice on NC diet ( Figure S6M ).
Based on the fact that newborn Tcf7l2 À/À and adult LTCF4KO
showed decreased blood glucose levels upon fasting, we assessed the hepatic response to long-term fasting in LTCF4KO mice. Blood glucose measurements were taken from LTCF4KO mice along with control littermates at regular intervals during a 24 hr fasting period. We found significantly reduced blood glucose levels between LTCF4KO and control mice from 9 hr onward during the 24 hr fasting period (p < 0.05) ( Figure 7A ). No differences in blood glucose levels were observed in mice fed ad libitum with NC diet (Figures 7A and S6G) . To explore the possible mechanism underlying the reduced glucose levels observed in LTCF4KO mice during long fasting periods, we compared microarray data from livers of control mice in fed and 24-hr-fasted states in order to identify the genes upregulated in response to fasting. 623 genes were differentially expressed between fed and 24-hr-fasted control livers (as defined by being >2-fold upregulated; p < 0.05) (Table S5 and Figure 7B ). The induction of this set of genes upon fasting was generally much less prominent in LTCF4KO samples (Table S5 and Figure 7B) . GSEA analysis showed a significant enrichment of genes with at least one TCF4 peak within 5 kb from the TSS among the genes differentially expressed between LTCF4KO versus control livers fasted during 24 hr (24-hr-fasted p < 0.001 versus fed p < 0.789) ( Figure 7C and data not shown). Furthermore, GSEA analysis showed a significant enrichment of metabolic pathways, such as glycolysis and gluconeogenesis, biosynthesis of steroids, and fatty acid metabolism in the set of genes that were lower in 24-hr-fasted LTCF4KO livers when compared with 24-hr-fasted control livers (Table S6 ). In contrast, GSEA did not find any metabolic category significantly enriched when fed LTCF4KO livers were compared with fed control livers (data not shown).
Between fed and 24-hr-fasted control livers, we noted an upregulation of the generic Wnt targets genes Axin2 and Sp5 (Figure S7H) , implying that the Wnt pathway is activated upon fasting. This induction did not occur in the LTCF4KO livers (Figure S7H) . The liver-zonated Wnt/b-catenin target genes Glul and Rnase4 were also significantly upregulated during fasting in a TCF4-dependent fashion ( Figure S7H ). This implied that TCF4 is involved in a Wnt-driven transcriptional response to fasting. In agreement, fasting increased Wnt2b, Wnt4, and Wnt9b expression in control liver ( Figure S6C ). We also examined the hepatic mRNA levels of known genes involved in fasting such as Aldh3a2, St3gal5 (Sanderson et al., 2009) , and Slc1a2 (Table  S5 and Figure 7D ). Expression was upregulated after 24 hr of fasting, and their induction was abolished by TCF4 ablation (p < 0.01) ( Figure 7D) . Additionally, the fasting-mediated mRNA induction of one of the key gluconeogenic enzymes, G6pc, was significantly reduced in LTCF4KO liver samples (p < 0.05) ( Figure 7D ). Importantly, analysis of the ChIP-seq data and qPCR demonstrated the presence of TCF4 peaks in near metabolic genes involved in the response to fasting such as G6pc, Aldh3a2, and Slc1a2 ( Figures 6B, 6E , S5B, and S5C). Of note, TCF4 was not significantly enriched in the vicinity of Pck1, Fbp1, and St3gal5 genes ( Figures 6B, 6E , S5B, and S5C).
LTCF4KO Mice Display Reduced Hepatic Gluconeogenesis
To assess the effect of liver-specific TCF4 depletion on whole-body glucose utilization, LTCF4KO and control mice were fed with either NC or HF diet. We observed no significant differences in body weight, gain of weight, and food intake between LTCF4KO and control mice on HF diet during an 8 week period (Figures S6D-S6F ). However, we observed significantly reduced glucose levels in fasting LTCF4KO mice when compared to control mice (p < 0.05) ( Figure S6J) . This reduced glucose level was not caused by hyperinsulinemia ( Figures S6K and S6L) . Indeed, glucose-stimulated insulin secretion did not differ between LTCF4KO and control mice (Figure S6N ) on HF diet. Intraperitoneal GTT were performed on LTCF4KO and control mice maintained on both diets. Although we observed a mild phenotype in LTCF4KO mice fed with NC diet (Figure S7A ), upon challenge with HF diet, the mice exhibited a significantly lower increase in glucose levels (p < 0.05) ( Figure S7B ). Following injection of pyruvate, we also observed that glucose levels were lower in LTCF4KO mice on NC diet ( Figure 7E ) and became significantly less increased in LTCF4KO upon challenge with HF diet (p < 0.05) ( Figure 7F ). Collectively, these results indicated that LTCF4KO mice have a reduced hepatic gluconeogenesis that becomes more pronounced when mice are challenged with HF diet. To directly examine the effect of TCF4 deficiency on hepatic glucose production in vitro, hepatocytes from control and LTCF4KO mice on HF diet were isolated and assayed in culture. TCF4 null hepatocytes secreted less glucose than controls following either glucagon or IBMX (3-isobutyl-1-methylxanthine) stimulation, indicating an intrinsic impairment of glucose production ( Figure S7C ). The induction of TCF4-dependent G6pc and Aldh3a2 mRNA levels in response to glucagon stimulation, as a surrogate of fasting, was significantly abrogated in LTCF4KO hepatocytes (p < 0.05) ( Figure S7D ).
Effects of Liver-Specific Overexpression of TCF4 In Vivo Opposite to LTCF4KO Adult liver-specific Tcf7l2 knockout mice (LTCF4KO) showed reduced blood glucose levels and hepatic glucose production. To determine whether overexpression of TCF4 specifically in the liver induces the opposite phenotype, we analyzed the metabolic effects after transient hepatic overexpression of TCF4 by using replication-deficient adenovirus administered by tail vein injection into adult mice (Fechner et al., 1999) . In mice injected with TCF4 adenovirus (Ad-TCF4), $50% of the nuclei displayed increased expression of TCF4 ( Figure 7G , right, white arrowheads). Ad-TCF4-injected mice displayed a significant increase in serum glucose under fasting conditions ( Figure S7E ) compared to controls. This difference was not due to a reduction in circulating insulin concentrations (Figures S7F and S7G) . Consistent with our observation after liver-specific deletion of TCF4, overexpression of TCF4 specifically in the liver led to an increased hepatic glucose production upon pyruvate injection ( Figure 7H) . qPCR analyses revealed an upregulation of the generic Wnt target genes (Axin2 and Sp5) and liver-zonated genes (Glul and Rnase4) (p < 0.05) ( Figure S7I ), implying that elevating TCF4 indeed enhances the transcriptional Wnt response. This induction also occurred for the metabolic genes that were direct targets of TCF4 (Aldh3a2, St3gal5, Slc1a2, and G6pc) (p < 0.05) ( Figure 7I ). Of note, metabolic genes that were not TCF4 targets (Pck1 and Fbp1) were not upregulated after TCF4 overexpression ( Figure 7I ). Thus, in the adult liver, genetic overexpression of TCF4 leads to the opposite effect of removal of TCF4 in terms of glucose metabolism and of expression of the Wnt-responsive metabolic genes.
DISCUSSION
Most studies on the involvement of TCF7L2 SNP variants in type 2 diabetes (T2D) focus on a role of TCF4 in pancreatic islets and b cells (da Silva Xavier et al., 2009; Lyssenko et al., 2007; Shu et al., 2008 Shu et al., , 2009 . In this study, we utilize mouse genetics to show that removal of TCF4 from b cells does not affect their function. These observations are made in newborn Tcf7l2 À/À mice and in adult b-cell-specific Tcf7l2 mutants, challenged by fasting or by high-fat diet. The previously reported changes in b cell function possibly result indirectly from changes elsewhere in the body. In this study, we have focused on the transcriptional role of TCF4 in liver metabolism. We believe it highly likely that (D) GSEA showing a significant enrichment of genes bound by TCF4 among the genes downregulated in Tcf7l2 À/À newborn livers.
(E) qPCR was performed to determine enrichment of TCF4 and IgG control in the proximal promoters and enhancers of several TCF4 target genes.
(F) Luciferase units relative to the activity detected of the respective empty vector.
(G) Same constructs described above were cotransfected with control or DNTCF4 (dominant-negative TCF4) plasmid. Values were normalized to the luciferase activity of the respective empty vector. Data are represented as mean ±SEM from three independent experiments. *p < 0.05, **p < 0.01, and ***p < 0.001. See also Figure S5 and Tables S2, S3 , and S4. a Wnt/TCF4 axis may similarly control transcriptional responses to metabolic challenge in, for instance, muscle or white adipose tissue. The Wnt pathway controls postnatal hepatic growth (Apte et al., 2007) and postnatal liver zonation (Spear et al., 2006) . We now show that TCF4 controls physiological energy-related functions of the neonatal and adult liver and that Wnt target genes are activated in response to metabolic demand in a TCF4-dependent manner. We thus identify a liver-specific TCF4-controlled gene program. Importantly, this liver-specific set of TCF4 target genes includes some generic Wnt target genes, but it otherwise mainly covers pathways related to metabolism, such as gluconeogenesis, transport of fatty acids, and synthesis of ketone bodies.
The current observations imply the following scenario. TCF4 is dispensable during embryonic development, likely due to redundancy with other TCF/LEF family members (Gregorieff et al., 2004) . Moreover, it is not required for the baseline expression of its metabolic target genes throughout life, yet its function in metabolic control becomes evident under situations of metabolic demand. Its first essential role is revealed directly after birth. The immediate postnatal surge in the production of energy carriers by the liver (when placenta function is acutely disrupted) does not occur in TCF4 mutant mice, leading to their rapid death. Indeed, a large set of key metabolic liver genes are dependent on TCF4 for their induced expression after birth. We find that many of these genes are physically occupied by TCF4. Several generic Wnt target genes (Axin2 and Sp5), as well as Wnt target liver-zonated genes (Glul and Rnase4), are coregulated with the set of metabolic TCF4 target genes. Several Wnt ligands are induced perinatally. This metabolic function of TCF4 is conserved into adulthood. Similar to our observations in Tcf7l2 mutant newborns, fasting adult mice carrying a liver-specific Tcf7l2 null mutation fail to induce generic Wnt target genes and metabolic genes involved in hepatic glucose production. As in the neonate, fasting induces several Wnt ligands. Taken together, Wnt signals activate the ''surges'' in liver metabolism that occur in the immediate postnatal period and upon metabolic demand in the adult.
In accordance with this, a recent study has used a transgenic mouse approach to demonstrate that the diabetes-associated SNP variants of the TCF7L2 locus give rise to gain-of-expression alleles (Savic et al., 2011) . Our adenovirus experiment demonstrates that increased liver-specific expression of TCF4 leads to increased glucose production. Indeed, an increase in fasting hepatic glucose production has been observed in human carriers of TCF7L2 risk alleles (Lyssenko et al., 2007; Pilgaard et al., 2009 ). These observations may provide a molecular framework from which to understand the role of TCF7L2/TCF4 in the development of diabetes.
EXPERIMENTAL PROCEDURES Animals
All different mouse models generated and analyzed are described extensively in the Supplemental Information.
Glucose and Insulin Tolerance, Insulin Secretion, Pyruvate Challenge, and Long-Term Fasting Tests For glucose (GTT) and pyruvate (PTT) tolerance tests, mice were deprived of food for 16 hr and were injected i.p. with either glucose or pyruvate (2 g/kg body weight). Glucose from tail vein blood was then measured at time 0, 15, 30, 60, and 120 min. For insulin tolerance test (ITT), mice were deprived of food for 4 hr and were injected i.p. with insulin (0.75 units/body weight). Glucose from tail vein was then measured at time 0, 15, 30, 60, and 90 min. For glucose-stimulated insulin secretion test, mice were deprived of food for 16 hr and injected i.p. with glucose (3 g/kg body weight), and blood was collected from the tail vein at 0 and 15 min after injection. For long-term fasting experiments, blood was sampled from the tail vein of mice, which were allowed to feed ad libitum (time 0) or fasted for 3, 6, 9, 12, or 24 hr. Blood glucose concentrations were always measured with Glucometer FreeStyle (Abbott).
Serum Biochemical Measurements
Serum blood samples were collected with Microvette CB300 capillary (Sarstedt). Plasma insulin (Mercodia), free fatty acid (BioVision), triglycerides (BioAssay systems), and ketone body (BioVision) measurements were performed by ELISA. were then determined by using the Amplex Red Glucose/Glucose Oxidase Assay Kit (Invitrogen). Samples incubated in the absence of amyloglucosidase were used as a baseline controls. In case of measuring triglyceride levels, liver samples were homogenized in chloroform: methanol (2:1) (500 ml/50 mg tissue). 100 ml of 0.9% NaCl were added, and samples were vortexed for 2 min and centrifuged at 2,000 rpm for 5 min. Organic phase was recovered and lyophilized. Samples were resuspended in PBS-1%Triton before measurement.
Glycogen and Triglyceride Assays
Pancreatic Islet Isolation, Insulin Secretion, and Insulin Content Pancreatic islets from bTCF4KO, LTCF4KO, and respective control mice were isolated as previously described (Pá rrizas et al., 2001) . For secretion studies, pancreatic islets were allowed to recover for 1 day in culture in RPMI containing 11 mM glucose supplemented with 10% fetal calf serum and penicillinstreptomycin at 37 C and 5% CO 2 . Equal numbers of size-matched islets were subjected to stimulation of insulin secretion at 1.6 and 16.7 mM glucose. After 1 hr of incubation in each condition, medium was collected, and insulin levels were assessed by ELISA. To measure insulin content in isolated islets, Tables S5  and S6. pancreatic islets were sonicated in acid ethanol on ice for 15 s three times. All extracts were stored at À20 C for subsequent ELISA.
RNA Extraction, Microarray Analysis, and RT-PCR Total RNA was obtained from embryonic, newborn, and adult liver, newborn pancreas, and adult isolated pancreatic islets and hepatocytes. RNA extraction and reverse transcription (RT) were performed as described (Pá rrizas et al., 2001) . For expression profile comparison between 5 hpp Tcf7l2 À/À
and Tcf7l2 +/+ livers and between fed and 24-hr-fasted control and LTCF4KO
livers, 1 mg of total RNA from four liver samples for each genotype, together with universal mouse reference RNA (Stratagene), were labeled by using Quick Amp Labeling Kit (Agilent Technologies) with Cy5 and Cy3, respectively. Samples were hybridized on 4x44K Whole Mouse Genome Microarrays (Agilent, G4122F) according to manufacturer's instruction. Microarray signal and background information were retrieved by using Feature Extraction (V.9.5.3., Agilent Technologies). For each pair of experiments, fluorescent signals in either channel with greater than 2-fold above the background were considered. Genes that were present in less than three out of eight arrays (four pairs of control and mutant samples for each comparison) were excluded from further analysis. Corresponding fold changes greater than 2-fold variations between average of the control and mutant samples with p < 0.05 (Student's t test) were considered as significant. The data were mean centered across samples for comparison in Figure 5A . The comparison between 5 hpp Tcf7l2 À/À and Tcf7l2 +/+ livers resulted in 960 significant unique genes differentially expressed in Tcf7l2 À/À postnatal liver samples (Table S1 ).
The comparison between 24-hr-fasted versus fed adult control and LTCF4KO livers resulted in 623 unique genes significantly less upregulated in LTCF4KO samples (Table S5) . Selected candidate genes were further validated by qRT-PCR. qRT-PCR was performed on iCycler iQ Real-Time PCR Detection Systems (Bio-Rad) by using iQ SYBR Green supermix (Bio-Rad). All qRT-PCR results were normalized to Tbp mRNA levels. Similar results were obtained when using Hprt and b-actin to normalize. In Figures 3, 4 , and 5, the WT embryonic samples were used as a reference and were compared to the mutant embryonic, WT newborn, and mutant newborn samples. In Figure 7 , the fed control samples were used as a reference and were compared to the fed mutant, fasted control, and fasted mutant samples. Primer sequences are described in Table S7 .
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Array data are available at Gene Expression Omnibus (http://www.ncbi.nlm. nih.gov/geo) with GEO number GSE41284.
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